Page last updated: 2024-11-05

ethylhexadecyldimethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethylhexadecyldimethylammonium: a disinfectant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31281
CHEMBL ID1550879
SCHEMBL ID41715
MeSH IDM0513064

Synonyms (38)

Synonym
ethyl-hexadecyl-dimethyl-ammonium
MLS001335953 ,
smr000875346
NCGC00166120-01
inchi=1/c20h44n/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(3,4)6-2/h5-20h2,1-4h3/q+1
vcavaurzpnandq-uhfffaoysa-
ethyl-hexadecyl-dimethylazanium bromide
ethyl-hexadecyl-dimethylazanium
A805187
ethyl-hexadecyl-dimethylammonium
ethyl-hexadecyl-dimethyl-azanium
ethylhexadecyldimethylammonium
mecetronium cation
cetyl ethyldimonium
mecetronium ion
cetyl ethyldimonium cation
cetyl ethyldimonium ion
cetyldimethylethylammonium ion
cetyldimethylethylammonium cation
CHEMBL1550879
mecetronium
unii-17t62wr2ki
17t62wr2ki ,
10328-33-3
hexadecyldimethylethylammonium
cetyldimethylethylammonium
ammonium, ethylhexadecyldimethyl-
1-hexadecanaminium, n-ethyl-n,n-dimethyl
SCHEMBL41715
dimethylethylhexadecylammonium
DTXSID2047729
ethyl-hexadecyl-dimethylammonium;bromide
ethyl-hexadecyl-dimethyl-azanium;bromide
cetyl-ethyl-dimethyl-ammonium;bromide
bdbm58926
cid_31280
cetyldimethlethylammonium
Q27251933
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency79.43280.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency17.78280.031637.5844354.8130AID504865
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency50.11870.354828.065989.1251AID504847
huntingtin isoform 2Homo sapiens (human)Potency14.12540.000618.41981,122.0200AID1688
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency89.12510.010323.856763.0957AID2662
gemininHomo sapiens (human)Potency10.01710.004611.374133.4983AID624296; AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency18.37600.005612.367736.1254AID624032; AID624044
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency31.62280.060110.745337.9330AID492961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's11 (68.75)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.73 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (25.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (68.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]